Baxter International Inc
(BAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,726,000 | 1,686,000 | 2,294,000 | 1,764,000 | 1,420,000 |
| Receivables | 1,777,000 | 1,773,000 | 1,646,000 | 1,679,000 | 1,729,000 |
| Inventories | 2,460,000 | 2,384,000 | 2,170,000 | 2,046,000 | 2,103,000 |
| Other current assets | 0 | 0 | 0 | 2,611,000 | 2,892,000 |
| TOTAL | $6,933,000 | $6,749,000 | $7,035,000 | $8,853,000 | $8,864,000 |
| Non-Current Assets | |||||
| PPE Net | 2,812,000 | 2,802,000 | 2,717,000 | 2,870,000 | 2,833,000 |
| Intangibles | 10,205,000 | 10,345,000 | 10,419,000 | 10,498,000 | 11,232,000 |
| Other Non-Current Assets | 1,117,000 | 1,150,000 | 1,133,000 | 3,561,000 | 3,747,000 |
| TOTAL | $14,134,000 | $14,297,000 | $14,269,000 | $16,929,000 | $17,812,000 |
| Total Assets | $21,067,000 | $21,046,000 | $21,304,000 | $25,782,000 | $26,676,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 755,000 | 8,000 | 662,000 | 2,752,000 | 2,498,000 |
| Accounts payable and accrued liabilities | 953,000 | 995,000 | 963,000 | 968,000 | 841,000 |
| Accrued Expenses | 2,067,000 | 1,936,000 | 1,856,000 | 1,861,000 | 1,772,000 |
| TOTAL | $3,775,000 | $2,939,000 | $3,481,000 | $6,511,000 | $6,200,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,747,000 | 9,492,000 | 9,412,000 | 10,374,000 | 10,437,000 |
| Other Non-Current Liabilities | 1,331,000 | 1,322,000 | 1,357,000 | 1,871,000 | 2,093,000 |
| TOTAL | $10,078,000 | $10,814,000 | $10,769,000 | $12,247,000 | $12,534,000 |
| Total Liabilities | $13,853,000 | $13,753,000 | $14,250,000 | $18,758,000 | $18,734,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 514,056 | 513,621 | 513,175 | 511,625 | 510,588 |
| Common Shares | 683,000 | 683,000 | 683,000 | 683,000 | 683,000 |
| Retained earnings | 14,837,000 | 14,970,000 | 14,968,000 | 14,929,000 | 15,529,000 |
| Other shareholders' equity | -3,760,000 | -3,773,000 | -3,969,000 | -3,950,000 | -3,577,000 |
| TOTAL | $7,214,000 | $7,293,000 | $7,054,000 | $7,024,000 | $7,942,000 |
| Total Liabilities And Equity | $21,067,000 | $21,046,000 | $21,304,000 | $25,782,000 | $26,676,000 |